The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats

European Journal of Neuroscience

Volumn 13, Issue 1, 2001, Pages 162-170

  Treseder, S A ^a   Rose, S ^a   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Central AADC inhibition; Contralateral circling behaviour; Monoamine oxidase inhibition; Wistar rats

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; 3 O METHYLDOPA; 3,4 DIHYDROXYPHENYLACETIC ACID; 6 HYDROXYDOPA; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CARBIDOPA; DOPA DECARBOXYLASE INHIBITOR; DOPAMINE; HOMOVANILLIC ACID; LEVODOPA; MONOAMINE OXIDASE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPA DECARBOXYLASE; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; DRUG COMBINATIONS; ENZYME INHIBITORS; HALOPERIDOL; HOMOVANILLIC ACID; HYDRAZINES; LEVODOPA; MALE; MEDIAL FOREBRAIN BUNDLE; OXIDOPAMINE; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR;

EID: 0035190221     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2000.01370.x     Document Type: Article

References (47)

1. Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-OHDA-treated rats
2. 3H] gamma-aminobutyric acid in the basal ganglia of 6-OHDA lesioned rats
3. Chronic L-DOPA treatment in the unilateral 6-OHDA rat: Evidence for behavioural sensitization and bochemical tolerance
4. In vivo measurement of tryptophan and tyrosine hydroxylase activities in rat brain
5. The effect of reserpine treatment in-vivo upon L-dopa and amphetamine evoked dopamine and dopac efflux in-vitro from the corpus striatum of male-rats
6. The aromatic amino-acid decarboxylase inhibitor, NSD-1015, increases release of dopamine response characteristics
7. Effect of decarboxylase inhibitors on brain p-tyrosine levels
8. Dual effects of L-3,4dihydroxyphenylalanine on aromatic L- amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: Evidence that behaviour is dopamine independent
9. Dopamine oxidation and its inhibition by (-) -deprenyl in man
10. A comparison of the effects of decarboxylase inhibitors on L-DOPA-induced circling behaviour and the conversion of DOPA to dopamine in the brain
11. Biphasic actions of L-Dopa on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices
12. L-DOPA facilitates the release of endogenous norepinephrine and dopamine via presynaptic B1 and B2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices
13. L-Dopa methyl-ester antagonizes competitively L-Dopa-induced facilitation of noradrenaline release from rat hypothalamic slices
14. Picomolar concentrations of L-Dopa stereoselectively potentiate activities of presynaptic beta-adrenoceptors to facilitate the release of endogenous noradrenaline from rat hypothalamic slices
15. L-Dopa induces Ca2+-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices
16. Evidence for dopamine deamination by both type A and type B monoamine oxidasi in rat brain in vivo and for the degree of inhibition of the enzyme necessary for increased functional activity of dopamine and 5hydroxytryptamine
17. Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors
18. Circling behaviour in rats with partial, unilateral nigrostriatal lesions: Effect of amphetamine, apomorphine, and dopa
19. 11C]-raclopride binding in the rat striatum, quantified using PET
20. Inhibition of aromatic L-amino-acid decarboxylase under physiological conditions - Optimization of 3-hydroxybenzylhydrazine concentration to prevent concurrent inhibition of monoamine-oxidase
21. Evidence for L-DOPA systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat
22. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and seritonergic neurones
23. NSD-1015 alters the geneexpression of aromatic L-amino acid decarboxylase in rat PC12 pheochromocytoma cells
24. Suppresion of L-dopa-induced circling in rats with nigral lesions by blockade of central dopadecarboxylase
25. Neurotransmitter-like actions of L-DOPA
26. Biphasic actions of L-dopa on the release of endogenous dopamine via presynaptic receptors in rat striatal slices
27. Nanomolar L-dopa induces Ca2+-dependent and tetrodotoxin-sensitive release of glutamate from striata of conscious rat
28. Agonist -induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning
29. A new and highly sensitive voltammetric assay for L-amino acid decarboxylase activity by High-Performance Liquid Chromatography
30. Transmitter-like basal and K+-evoked release of 3,4- dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis
31. Non-effective doses of exogenously applied L-DOPA itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities in conscious rats
32. Effect of exogenous L-DOPA on behavior in the rat: An in vivo voltammetric study
33. The deamination of dopamine by human brain monoamine oxidase. Specificities for the two enzyme forms in seven brain regions
34. Effects of Ca2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis
35. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following Ldopa administration to rats
36. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum
37. 3H]dopamine from rat striatel slices
38. Pharmacological effects of L-dopa are not closely linked temporally to striatal dopamine concentration
39. Immunocytochemical localization of monoamine oxidase A and b in human peripheral tissues and brain
40. The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates
41. Use of intracerebral injections of 6-hydroxydopamine as a tool for morphological and functional studies on central catecholaminergic neurones
42. Quantitative recording of rotational behavour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system
43. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine treated rats: Differential effects of monoamine oxidase A and B inhibitors
44. Endogenously released L-DOPA itself tonically functions to potentiate postsynaptic D2 receptor mediated locomotor activities of conscious rats
45. Simultaneous measurement of dopamine release and rotational behaviour in 6hydroxydopamine denervated rats using intracerebral dialysis